|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Restructuring charges | |||||
| Transaction expenses | |||||
| Impairment of long-lived assets | |||||
| Goodwill impairment | |||||
| Operating loss | |||||
| Interest expense | |||||
| Interest income | |||||
| Net increase in fair value of derivatives | |||||
| Loss on extinguishment of debt | |||||
| Other expense (income), net | |||||
| Loss before taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Basic net loss per share (in usd per share) | |||||
| Diluted net loss per share (in usd per share) | |||||
| Weighted-average shares outstanding: | |||||
| Weighted-average shares outstanding, Basic (in shares) | |||||
| Weighted-average shares outstanding, Diluted (in shares) | |||||
| Other comprehensive (loss) income | |||||
| Unrealized gains on AFS investments, net of tax (expense) benefit | |||||
| Foreign currency translation | |||||
| Total other comprehensive (loss) income | |||||
| Total comprehensive loss |
Loading...
